Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis

European Journal of Haematology

Volumn 89, Issue 1, 2012, Pages 42-46

  Kristensen, Thomas ^a   Broesby Olsen, Sigurd ^a   Vestergaard, Hanne ^a   Bindslev Jensen, Carsten ^a   Møller, Michael B ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood; Indolent systemic mastocytosis; ISM; KIT D816V; Mutation

Indexed keywords

CD34 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; STEM CELL FACTOR;

ADULT; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CANCER CELL; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MAST CELL; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC MASTOCYTOSIS;

ADULT; AGED; AMINO ACID SUBSTITUTION; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; MUTATION; NEOPLASTIC CELLS, CIRCULATING; PROTO-ONCOGENE PROTEINS C-KIT; YOUNG ADULT;

EID: 84862587210     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2012.01789.x     Document Type: Article

References (10)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008: 54-63.
2. Garcia-Montero AC, Jara-Acevedo M, Teodosio C, et al.KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006;108:2366-72.
3. Escribano L, Alvarez-Twose I, Sanchez-Munoz L, et al.Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol 2009;124:514-21.
4. Orfao A, Garcia-Montero AC, Sanchez L, Escribano L Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol 2007;138:12-30.
5. Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, McClure RF, Li CY, Pardanani A Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009;113:5727-36.
6. Metcalfe DD Mast cells and mastocytosis. Blood 2008;112:946-56.
7. Akin C Clonality and molecular pathogenesis of mastocytosis. Acta Haematol 2005;114:61-9.
8. Kristensen T, Vestergaard H, Moller MB Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. J Mol Diagn 2011;13:180-8.
9. Fontalba A, Real PJ, Fernandez-Luna JL, Agirre X, Prosper F, Richard C Identification of c-Kit gene mutations in patients with polycythemia vera. Leuk Res 2006;30:1325-6.
10. Georgin-Lavialle S, Lhermitte L, Baude C, et al.Blood CD34-c-Kit+ cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor. Blood 2011;118:5246-9.